Jacobs Levy Equity Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-144,611
| Closed | -$4.1M | – | 955 |
|
|
2023
Q2 | $4.1M | Sell |
144,611
-469,922
| -76% | -$13.3M | 0.02% | 437 |
|
|
2023
Q1 | $14.1M | Buy |
614,533
+145,787
| +31% | +$3.35M | 0.09% | 236 |
|
|
2022
Q4 | $13.2M | Sell |
468,746
-17,980
| -4% | -$505K | 0.09% | 245 |
|
|
2022
Q3 | $13.8M | Buy |
486,726
+89,711
| +23% | +$2.54M | 0.11% | 207 |
|
|
2022
Q2 | $8.8M | Sell |
397,015
-68,837
| -15% | -$1.53M | 0.07% | 303 |
|
|
2022
Q1 | $13.6M | Buy |
465,852
+157,811
| +51% | +$4.59M | 0.09% | 242 |
|
|
2021
Q4 | $10.1M | Buy |
308,041
+5,494
| +2% | +$181K | 0.07% | 302 |
|
|
2021
Q3 | $14M | Buy |
302,547
+84,525
| +39% | +$3.9M | 0.09% | 242 |
|
|
2021
Q2 | $12M | Buy |
218,022
+14,746
| +7% | +$813K | 0.08% | 258 |
|
|
2021
Q1 | $10.5M | Buy |
203,276
+86,690
| +74% | +$4.48M | 0.08% | 287 |
|
|
2020
Q4 | $5.05M | Sell |
116,586
-19,701
| -14% | -$854K | 0.04% | 396 |
|
|
2020
Q3 | $4.77M | Buy |
136,287
+92,090
| +208% | +$3.22M | 0.05% | 350 |
|
|
2020
Q2 | $2.36M | Buy |
+44,197
| New | +$2.36M | 0.03% | 496 |
|
|
2018
Q1 | – | Sell |
-15,500
| Closed | -$886K | – | 992 |
|
|
2017
Q4 | $886K | Buy |
+15,500
| New | +$886K | 0.02% | 640 |
|
|
2016
Q4 | – | Sell |
-78,537
| Closed | -$4.15M | – | 951 |
|
|
2016
Q3 | $4.15M | Buy |
78,537
+45,347
| +137% | +$2.4M | 0.07% | 295 |
|
|
2016
Q2 | $1.39M | Buy |
+33,190
| New | +$1.39M | 0.03% | 500 |
|